acid reflux and tirzepatide S643 Assessing Risk of Gastroesophageal Reflux... : American Journal of Gastroenterology is acid reflux a side

A 2001 study examined how a dose of glucagon-like peptide-1 (GLP-1) infusion affected feelings of hunger and energy metabolism

Clinical research shows that tirzepatide, a dual GLP-1 and GIP receptor agonist, significantly quiets this mental interference by regulating appetite centers in the brain

Clinical trials demonstrate that tirzepatide-treated patients continue losing weight at higher percentages than semaglutide-only responders

The OGTT is now the preferred diagnostic test for dumping syndrome 1,20,85

In longer-term studies, such as STEP 5, participants maintained an average weight loss of 15.2% after 104 weeks with semaglutide 2.4 mg, compared to just 2.6% with placebo

If their followers dont see results